1. Home
  2. BTMD vs BYSI Comparison

BTMD vs BYSI Comparison

Compare BTMD & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biote Corp.

BTMD

Biote Corp.

N/A

Current Price

$0.84

Market Cap

31.0M

Sector

Health Care

ML Signal

N/A

Logo BeyondSpring Inc.

BYSI

BeyondSpring Inc.

N/A

Current Price

$0.44

Market Cap

25.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BTMD
BYSI
Founded
2012
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.0M
25.5M
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
BTMD
BYSI
Price
$0.84
$0.44
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
★ $2.22
N/A
AVG Volume (30 Days)
84.3K
★ 127.4K
Earning Date
11-04-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 722.22
N/A
EPS
N/A
★ N/A
Revenue
★ $192,219,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.95
$49.96
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.93
$0.42
52 Week High
$2.90
$2.44

Technical Indicators

Market Signals
Indicator
BTMD
BYSI
Relative Strength Index (RSI) 32.21 38.95
Support Level N/A $0.42
Resistance Level $1.24 $0.85
Average True Range (ATR) 0.09 0.10
MACD -0.02 -0.01
Stochastic Oscillator 0.00 2.85

Price Performance

Historical Comparison
BTMD
BYSI

About BTMD Biote Corp.

Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.

About BYSI BeyondSpring Inc.

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment. Its first asset, Plinabulin is a novel brain-penetrant microtubule modulator with dendritic cell maturation and vasculature modulation mechanism, which has the potential to help mitigate acquired resistance from prior immune checkpoint inhibitors (ICI) treatment in cancer patients. It is a Selective Immunomodulating Microtubule-Binding Agent (SIMBA), which may provide multiple therapeutic opportunities.

Share on Social Networks: